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A. Specific Aims 
A . l Specific Aim 1: To determine if a component of scorpion venom inhibits C1C 
channels, and determine the mechanism of inhibition. 
Aim 1A: Using electrophysiological techniques we will assay for inhibitory activity of 
Leiurus quinquestriatus hebraeus (Lqh) scorpion venom on C1C CP channels. We 
hypothesize that venom contains peptide toxins that will inhibit current through CIC 
channels, and that trypsinization of whole venom will abolish toxin activity, showing that 
the active component is a peptide. We will test this by examining whole cell currents in 
the presence and absence of venom for each channel, and will use trypsin to destroy 
peptide components of venom. 
Aim IB: We will determine the mechanism of inhibition by venom. We hypothesize that 
Lqh venom will inhibit gating of ClC-2 channels, rather than blocking the pore. To test 
this we will examine voltage-dependence of inhibition, as well as quantify any changes in 
the kinetics of activation and deactivation. 
A.2 Specific Aim 2: Isolate the active component. We hypothesize that the venom 
contains a single peptide that inhibits gating in the ClC-2 CI' channel. A combination of 
HPLC and mass spectrometry will be used to isolate and characterize the active 
component of the venom. Using two-electrode voltage clamp (TEVC), we will be able to 
probe for activity in the fractions obtained from HPLC. With a purified toxin, true dose 
response curves can be obtained, and thus a true K d can be measured. 
B. Progress towards Aim 1 
In the last update we showed that Lqh-venom contained a peptide component that slows 
ClC-2 channel activation. N o further work has been done on Aim 1 as all experimental 
hypotheses in this aim have been completed. Details of the work performed towards the 
completion of this aim have been published in the Journal of Membrane Biology. 
Thompson et al., 2005, J. Membr. Biol. 208: 65-76. 
C. Progress towards Aim 2 
The goal of this aim was to isolate the component of Lqh-venom that inhibits the 
ClC-2 CI- channel. In order to isolate the active component of this venom, we used 
reversed-phase HPLC (RP-HPLC) to separate the components of partially-fractionated 
venom, which contains only components smaller than 10 kDa. We tested each fraction 
for inhibition of ClC-2 currents using two-electrode voltage clamp (TEVC). With initial 
separation performed using a C3 column, we observed that the fraction collected from 0 -
10 minutes, Fraction A, retained activity similar to Lqh pf-venom (Fig. 1 A, 45.7 + 6% 
inhibition, fraction concentration 0.1 mg/mL equivalent, n = 3, p = 0.01). The brief 
minute windows in both control and experimental conditions. When no toxin was 
backfilled into the pipette, we observed no change in average window current over the 
course of the experiment (Fig. 3A). However, when 2 n M synthetic GaTx2 was 
backfilled into the pipette average window currents were drastically reduced (Fig. 3 A, B; 
80.4 + 2 .0% decrease). We repeated these experiments with varying concentrations of 
GaTx2 to obtain a dose-response curve, which provided K d = 1 1 p M and a Hill 
coefficient of ~ 1 . 
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retention time of the active component on the C3 column suggests that the toxin is very 
hydrophilic. 
Final isolation and purification of the active toxin was achieved through two 
successive rounds of RP-HPLC using a C I 8 column, as summarized in Figure IB and 
1C. The isolated toxin, peak #3 , eluted at ~12 minutes and was sufficient to fully 
recapitulate the activity observed for Lqh pf-venom when diluted to the same equivalent 
concentration (64.2 + 5 .3% inhibition at 0.1 mg/mL equivalent, n = 4, p = 0.025). Amino 
acid analysis performed during protein sequencing (see Fig. 3) revealed that this toxin 
was present at very low abundance, with a concentration equivalent to 0.1 mg/mL 
containing isolated toxin at a concentration of only 10 nM. A dose-response curve 
constructed using native purified toxin showed that the K d at V m = -160 m V is only 80 
pM. 
The toxin was then subjected to both MALDI-MS and Edman degradation. MS 
analysis revealed a single peptide component with a mass of 3191.5 Da; a double charged 
species was also apparent with m/z = 1.6 kDa (Fig. 2A). Edman degradation then 
revealed the peptide had a primary amino acid sequence of: 
V S C E D C P D H C S T Q K A R A K C D N D K C V C E P I 2 9 (Fig. 2B). Comparison of this 
sequence with the primary sequence of other known toxins reveals that our peptide 
matches exactly with a previously identified peptide known a Leiuropeptide II (LPII) 
(Fig. 2B). However, no target has ever been identified for LPII, and it was in fact 
proposed to be a K + channel inhibitor, not a CI" channel inhibitor. Thus, to avoid 
confusion we have renamed this peptide GaTx2. We created a homology model of 
GaTx2 based on the N M R structure of Neurotoxin POL GaTx2 maintains a fold very 
similar to that of other scorpion toxins, as is shown in Figure 2C, which compares the 
structures of Scyllatoxin, a Ca 2 + -act ivated K + channel inhibitor, GaTx2, and Chlorotoxin, 
which is from a related scorpion. The alpha-helix of GaTx2 is connected to 2 beta-strands 
via 3 disulfide bridges, which are the only post-translational modification of GaTx2. With 
this data that we have obtained over the last year we have completed the goals set forth in 
Specific Aim 2. 
Status: A manuscript describing this work is currently in preparation, with plans to 
submit to P N A S . 
D. Progress beyond Aim 2 
The next step in the characterization of GaTx2 is the production of the toxin in 
non-native setting in order for the production of large amounts of the toxin. Thus, we 
have synthesized GaTx2 via solid-phase chemical synthesis for this reason, and to 
confirm that the sequence associated with the native isolate toxin is indeed the active 
component from Lqh-venom. In order to test for activity of synthetic GaTx2, we recorded 
inside-out multi-channel patches, where the pipette was backfilled with varying 
concentrations of synthetic toxin. The pipette was backfilled in such a way as to allow 10 
minutes of control recording ( V m = -100 mV), followed by 10 minutes of recording in the 
presence of GaTx2. We then calculated the average window current of five separate four-
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Figure 1: Isolation of the active toxin. (A - C). Left: 
Representative RP-HPLC chromatograms of Lqh pf-venom 
(A) or active fractions (S, C). T h e area included in the gray 
boxes contains the active fraction. The elution gradient is 
represented by a dashed line. T h e middle panel presents 
summary data for fraction activity. Bars show mean ± SEM for 
3-10 observations. T h e right panel shows representative 
traces from TEVC experiments in the absence (black trace) or 
presence (gray trace) of the active fractions or isolated peak. 
(D). Dose-response curve from a single TEVC experiment for 
inhibition of CIC-2 at V M = -160 mV by 0.01, 0.1, 1, or 10 nM 
native toxin. Inset shows dose-response plotted on a log 
scale. 
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Figure 2: Proteomic characterization of GaTx2. (A) MALDI-MS analysis of peak 3. (B) Sequence 
alignment of GaTx2 with other previously identified, highly related toxins. Disulfide bridge 
connectivity is shown below the sequence alignment, while the predicted secondary structure is 
shown above the sequence. (C) Homology model of GaTx2 (middle) shown with the NMR structures 
of Scyllatoxin (left) and Chlorotoxin (right), in three orientations. The top panel shows disulfide 
bridges in bond representation. 
